Jesse Steffens

532 total citations
15 papers, 297 citations indexed

About

Jesse Steffens is a scholar working on Infectious Diseases, Epidemiology and Emergency Medical Services. According to data from OpenAlex, Jesse Steffens has authored 15 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 7 papers in Epidemiology and 2 papers in Emergency Medical Services. Recurrent topics in Jesse Steffens's work include Viral Infections and Outbreaks Research (12 papers), Viral Infections and Vectors (7 papers) and Hepatitis B Virus Studies (7 papers). Jesse Steffens is often cited by papers focused on Viral Infections and Outbreaks Research (12 papers), Viral Infections and Vectors (7 papers) and Hepatitis B Virus Studies (7 papers). Jesse Steffens collaborates with scholars based in United States, Australia and Germany. Jesse Steffens's co-authors include Sina Bavari, Sean A. Van Tongeren, Karen Martins, Christopher L. Cooper, Jay Wells, Steven A. Kwilas, James J. Moon, Sarah L. Norris, Andres Μ. Salazar and John M. Dye and has published in prestigious journals such as ACS Nano, PLoS ONE and Scientific Reports.

In The Last Decade

Jesse Steffens

14 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jesse Steffens United States	11	191	80	74	67	30	15	297
Trisha R. Barnard Canada	6	165 0.9×	58 0.7×	31 0.4×	118 1.8×	71 2.4×	7	302
Toshiki Sekiya Japan	9	64 0.3×	114 1.4×	121 1.6×	70 1.0×	19 0.6×	18	287
Katie A. Howell United States	9	276 1.4×	130 1.6×	37 0.5×	54 0.8×	15 0.5×	12	350
Sophia M. Vrba United States	6	160 0.8×	71 0.9×	130 1.8×	118 1.8×	27 0.9×	10	354
Stephanie Ascough United Kingdom	11	110 0.6×	120 1.5×	88 1.2×	114 1.7×	19 0.6×	18	309
Suzanne E. Wollen-Roberts United States	11	214 1.1×	111 1.4×	17 0.2×	59 0.9×	49 1.6×	17	293
Jonathan C. Guito United States	10	298 1.6×	146 1.8×	76 1.0×	57 0.9×	59 2.0×	18	463
Kyle Shifflett United States	9	179 0.9×	78 1.0×	18 0.2×	58 0.9×	23 0.8×	15	242
Marta Ulaszewska United Kingdom	11	181 0.9×	57 0.7×	52 0.7×	73 1.1×	49 1.6×	20	278
Sergio Gómez‐Medina Germany	11	236 1.2×	116 1.4×	86 1.2×	42 0.6×	129 4.3×	12	350

Countries citing papers authored by Jesse Steffens

Since Specialization

Citations

This map shows the geographic impact of Jesse Steffens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesse Steffens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesse Steffens more than expected).

Fields of papers citing papers by Jesse Steffens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesse Steffens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesse Steffens. The network helps show where Jesse Steffens may publish in the future.

Co-authorship network of co-authors of Jesse Steffens

This figure shows the co-authorship network connecting the top 25 collaborators of Jesse Steffens. A scholar is included among the top collaborators of Jesse Steffens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesse Steffens. Jesse Steffens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Kurup, Drishya, Nicole Josleyn, Eric R. Wilkinson, et al.. (2024). Inactivated rabies-based Lassa fever virus vaccine candidate LASSARAB protects nonhuman primates from lethal disease. npj Vaccines. 9(1). 143–143. 9 indexed citations

Warren, Travis K., Christopher D. Kane, Jay Wells, et al.. (2021). Remdesivir is efficacious in rhesus monkeys exposed to aerosolized Ebola virus. Scientific Reports. 11(1). 19458–19458. 12 indexed citations

Porter, Danielle, Jessica M. Weidner, Laura Gomba, et al.. (2020). Remdesivir (GS-5734) Is Efficacious in Cynomolgus Macaques Infected With Marburg Virus. The Journal of Infectious Diseases. 222(11). 1894–1901. 50 indexed citations

Cooper, Christopher L., et al.. (2020). Adjuvant selection impacts the correlates of vaccine protection against Ebola infection. Vaccine. 38(29). 4601–4608. 10 indexed citations

Steffens, Jesse, et al.. (2020). A Strategic Approach to Value Chain Upgrading—Adopting Innovations and Their Impacts on Farm Households in Tanzania. Horticulturae. 6(2). 32–32. 5 indexed citations

Martins, Karen, et al.. (2019). Glucopyranosyl lipid adjuvant enhances immune response to Ebola virus-like particle vaccine in mice. Vaccine. 37(29). 3902–3910. 17 indexed citations

Fan, Yuchen, Yao Xu, Jesse Steffens, et al.. (2019). Multilamellar Vaccine Particle Elicits Potent Immune Activation with Protein Antigens and Protects Mice against Ebola Virus Infection. ACS Nano. 13(10). 11087–11096. 35 indexed citations

Bazzill, Joseph, Lukasz J. Ochyl, Jesse Steffens, et al.. (2018). Vaccine nanoparticles displaying recombinant Ebola virus glycoprotein for induction of potent antibody and polyfunctional T cell responses. Nanomedicine Nanotechnology Biology and Medicine. 18. 414–425. 20 indexed citations

Fetterer, David P., Nicole L. Garza, Matthew G. Lackemeyer, et al.. (2018). A fixed moderate-dose combination of tiletamine+zolazepam outperforms midazolam in induction of short-term immobilization of ball pythons (Python regius). PLoS ONE. 13(10). e0199339–e0199339. 2 indexed citations

10.

Cooper, Christopher L., et al.. (2017). T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protection. Emerging Microbes & Infections. 6(1). 1–9. 13 indexed citations

11.

Martins, Karen, Christopher L. Cooper, Sarah L. Norris, et al.. (2015). Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine Immunity. EBioMedicine. 3. 67–78. 48 indexed citations

12.

Carra, John H., et al.. (2015). A thermostable, chromatographically purified Ebola nano-VLP vaccine. Journal of Translational Medicine. 13(1). 228–228. 14 indexed citations

13.

Martins, Karen, John H. Carra, Christopher L. Cooper, et al.. (2014). Cross-Protection Conferred by Filovirus Virus-Like Particles Containing Trimeric Hybrid Glycoprotein. Viral Immunology. 28(1). 62–70. 18 indexed citations

14.

Martins, Karen, Jesse Steffens, Sean A. Van Tongeren, et al.. (2014). Toll-Like Receptor Agonist Augments Virus-Like Particle-Mediated Protection from Ebola Virus with Transient Immune Activation. PLoS ONE. 9(2). e89735–e89735. 43 indexed citations

15.

Hirsch, H., et al.. (1961). [On the effect of barbituric acid and lytic cocktail on the time of resuscitation after tracheal clamping with simultaneous brain ischemia].. PubMed. 8. 628–32. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact